Immune reconstitution inflammatory syndrome: Immunopathogenesis, risk factors, diagnosis, treatment and prevention

Netherlands Journal of Medicine

Volumn 67, Issue 10, 2009, Pages 327-331

  Beishuizen, S J E ^a   Geerlings, S E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antiretroviral treatment; HIV infection; Immune reconstitution inflammatory syndrome

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; OPPORTUNISTIC INFECTION; REVIEW; RISK FACTOR; TUBERCULOSIS;

ADRENAL CORTEX HORMONES; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; RISK FACTORS;

EID: 70549087757     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. French MA, King Ms, Tschampa JM, et al. Immune Reconstitution Inflammatory Syndrome: A Reappraisal. Clin Inf Dis. 2009;48:101-107
2. Elston JWT, Thaker H. Immune reconstitution inflammatory syndrome. Int J STD&AIDS. 2009;20:221-224
3. Klotz SA, Woldemicheal MG, Mitku MW, Handrich M. Immune Reconstitution Inflammatory Syndrome in a Resource-Poor Setting. J Int Assoc Phys AIDS Care. 2009;8:122-127
4. Seddiki N, Sasson SC, Santer B, et al. Proliferations of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol. 2009;39:391-403.
5. De Boer M, Kroon FP, Kauffmann RH, et al. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics. Neth J Med. 2003;61:408-412 (Pubitemid 44344113)
6. Meintjes G, Rangaka MX, Maartens G, et al. Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis. 2009;48:667-676
7. Stone SF, Price P, Keane NM, Murray RJ, French MA. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med. 2002;3:21-27 (Pubitemid 34189592)
8. Manabe YC, Campbell JD, Sydnor E, et al. Immune Reconstitution Inflammatory Syndrome, Risk Factors and Treatment Implications. J Acquir Immune Defic Syndr. 2007;46:456-462 (Pubitemid 350098697)
9. Meintjes G, Wilkinson KA, Rangaka MX, et al. Type 1 Helper T Cells and FoxP3-positive T Cells in HIV-Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome. Am J Respir Crit Care Med. 2008;178:1083-1089
10. Bonham S, Meya DB, Bohjanen DR, et al. Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. Biomark Med. 2008;2:349-361
11. Zolopa A, Anderson J, Powderly W, et al. Early Antiretroviral therapy reduces AIDS Progression/death in individuals with acute opportunistic infections: A multicenter randomized strategy trial. PLoS ONE. 2009;4:e5575.
12. Meintjes G, Lynen L. Prevention and treatment of the immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS. 2008;3:468476.
13. Knysz B, Gladysz A. Immune reconstitution disease: Is it possible to establish recommendations? Postepy Hig Med Dosw. 2007;61:220-225
14. Battegay M, Drechsler H. Clinical spectrum of the immune restoration inflammatory syndrome. Curr Opin HIV AIDS. 2006;1:56-61.
15. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for the use in resource-limited settings. Lancet Infect Dis. 2008;8:516-523 (Pubitemid 352005824)
16. Dhasmana DJ, Dheda K, Ravn P, et al. Immune Reconstitution Inflammatory Syndrome in HIV-infected Patients Receiving Antiretroviral Therapy. Drugs. 2008;62:191-208.